title: Effects of atorvastatin on plasma fibrin clot properties in apparently healthy individuals and patients with previous venous thromboembolism.
authors.forename: Marek
authors.initials: M
authors.lastname: Zolcinski
authors.forename: Mariola
authors.initials: M
authors.lastname: Ciesla-Dul
authors.forename: Anetta
authors.initials: A
authors.lastname: Undas
mesh_terms: D000069059:Atorvastatin; D015415:Biomarkers / Q000097:blood; D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests; D016022:Case-Control Studies; D050171:Dyslipidemias / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D005337:Fibrin / Q000378:metabolism*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D011044:Poland; D011758:Pyrroles / Q000627:therapeutic use*; D016896:Treatment Outcome; D018615:Ultrasonography, Doppler, Color; D054556:Venous Thromboembolism / Q000097:blood / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*
chemical_list: D015415:Biomarkers; D005343:Fibrinolytic Agents; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D005337:Fibrin; D000069059:Atorvastatin